Dynamics, Gating and Opening in Enzyme Catalysis

Lead Research Organisation: University of Manchester
Department Name: Chemistry


The present application aims to get to the heart of fundamental, yet unanswered, questions that are critical to developing our understanding of how enzymes work. Enzymes, which are normally protein-based, control the rate at which almost all chemistry occurs in living systems. Understanding enzyme activity is a high priority - it is at the core of therapeutic intervention, industrial biotechnology, and synthetic biology. The controlled manipulation of enzyme activity is one of the key elements targeted in each of these areas of research. Enzyme activity has been studied for many decades and many paradigms have evolved but, very recently, tools have been developed that allow the testing of those paradigms with unprecedented levels of detail. Arguably foremost among these tools is NMR spectroscopy, which allows the observation of the structure, electronics and dynamics within enzymes at the level of individual atoms. A proper understanding of all of these elements and their interplay is crucial to manipulating enzyme activity, and with observation powers at this level of detail, paradigms are shifting. In this study we will address questions that are fundamental to the activity of almost all enzymes, namely what controls how fast the chemistry occurs, what makes an enzyme carry out one reaction against another, and what determines how well it binds to the chemicals on which it acts. To achieve this we will study the behaviour of an enzyme that moves phosphate groups around glucose. Enzymes that move phosphate groups lie at the heart of every system in living organisms - in the storage, maintenance and expression of genetic information, in metabolism, communication, cell architecture, differentiation, and homeostasis. We will develop new models based on the behaviour an archetypal enzyme that delivers very high quality measurements, which can then be translated to the enzymes that are common targets in therapeutic, industrial biotechnology and synthetic biology programmes.

Technical Summary

In order for an enzyme to be effective, it has to do much more than preferentially bind the transition state for the reaction. As a minimum, it has to bind and release the substrate(s) and product(s) with appropriate affinities and rates, and it has to set up the conformation(s) in which the chemical step occurs. Relating to all of these processes there are elements that are categorised under the heading of dynamics, but the picture of their involvement in catalysis is invariably clouded by the inability of the experiment to dissect which dynamics are associated with each element. Using an archetypal phosphoryl transfer enzyme, we have found ways to isolate key processes of catalysis. We aim to exploit this and the ever-evolving, sophisticated toolkit for the detailed examination of structure, electronics and dynamics within proteins to establish how this enzyme controls these elements of catalysis: namely, the chemical step, the timing and gating of near attack conformation formation, and the substrate/product release process. More specifically, the three questions that we will address are: Which dynamics specifically affect the chemical step in catalysis? Does gating determine that an enzyme acts as a mutase rather than a phosphatase? What determines how fast an enzyme dissociates its products? Our approaches to answering the individual questions are built around multi-dimensional heteronuclear NMR, X-ray, chemical, DFT and MM investigations of complexes of phosphoryl transfer enzymes. We have chosen beta-phosphoglucomutase as the principal study target on account of both its high tractability for the proposed study and preliminary data that have led to the proposal of new hypotheses about how catalysis is controlled.

Planned Impact

All biological and biology-based systems rely on enzymes for their constitution, and the manipulation of the activity of component enzymes is the primary means to translate knowledge of a system into an entity with significant impact. Correspondingly, improving means with which the activity of enzymes can be modulated specifically and controllably is a primary goal of a spectrum of industry ranging from pharmaceuticals through agrochemicals to industrial biotechnology. The experience of the last 20 years has illustrated beyond any doubt that progress in all of these fields requires a combination of screening methods and more detailed, knowledge-driven methods, where the proposed research has its primary impact. Every biological system known has a reliance on the enzyme-mediated transfer of phosphate groups to or from biomolecules. Unsurprisingly, therefore, phosphoryl transfer enzymes have been a focus for a wide spectrum of the academic community and for almost every major company targeting biological systems. Despite very substantial investment and the importance of the targets, progress worldwide in the development of reagents that interfere with the activity of phosphoryl transfer enzymes has been patchy. One of the principal problems is that our understanding of the operational details of these enzymes is not nearly as sophisticated as is desirable to guide product development. We seek to make a step change in the level of understanding of the activity of phosphoryl transfer enzymes, which will provide a more firm foundation upon which to build a more comprehensive scientific understanding of catalysis by enzymes with obvious industrial and medicinal benefits. While the work that we propose is of a fundamental nature, the targets that are relevant to our studies include entities that have been identified as some of the most desirable targets for therapeutic intervention in cancer and in heart disease.

The work will be disseminated to as wide an audience as possible. The primary source of dissemination of the results derived from the proposed studies will be through publication in high impact scientific journals. We have a long track record in publishing our research findings in major international, non-specialist journals, aimed at a broad interest readership. In addition, we will continue to disseminate the work at international scientific conferences that are highly attended by both academic and industrial delegates. Furthermore, we will continue our excellent track record in depositing and supporting data in publically accessible biological databases.

Outside of these academic-focussed activities, we have been engaged in numerous direct activities involving industry and non-specialist audiences. Much of the proposed work stems from discussions with representatives of two major UK pharmaceutical companies and two leading biotechnology companies, all with substantial interests in phosphoryl transfer enzymes, and all of which would benefit considerably from an improved understanding of the activity and control of these enzymes. Hence, their encouragement to address these fundamental issues from an academic perspective. Furthermore, the applicants are also developing new links with a leading agrochemical companies.

Longer term should our efforts lead to improved therapeutic treatments or biotechnology processes it will increase UK industrial competitiveness and benefit society. However, all research and knowledge also benefits society, for example public communication/schools visit describing a new piece of research may be the inspiration for a career in science.


10 25 50

publication icon
Jin Y (2017) Metal Fluorides as Analogues for Studies on Phosphoryl Transfer Enzymes. in Angewandte Chemie (International ed. in English)

publication icon
Leigh Katherine N. (2013) Computational studies of intermediate- and transition-state analogs in b-PGM in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY

Description We have utilized a range of experimental and computational tools to determine the structure, electronics and dynamics within proteins at the level of individual atoms. In particular we have unraveled the roles played by various states of a phosphoryl transfer enzyme, including many complexes involving the substrate and its analogues, in controlling the efficiency of catalysis. These studies have defined which components of the interactions between substrate and enzyme are responsible for maintaining the reaction along the desired pathway, how the enzyme avoids deleterious traps, and how the enzymes uses other traps to control how fast it operates. These studies will provide a firmer foundation upon which to accelerate progress in synthetic biology and enzyme-based biotechnology.
Exploitation Route Enzymes, which are normally protein-based, control the rate at which almost all chemistry occurs in living systems. Understanding enzyme activity is a high priority - it is at the core of therapeutic intervention, industrial biotechnology, and synthetic biology. The controlled manipulation of enzyme activity is one of the key elements targeted in each of these areas of research. The primary industrial beneficiaries of this work are in the biotechnological and pharmaceutical sectors. 1. This work will benefit researchers in the biotechnological industries by providing a firmer footing from which to reposition enzymes for industrial use. The specific issues to be addressed in the work packages are common issues with many enzymes and are often limiting factors in the efficiency of redesigned systems. 2. This work will benefit researchers in the pharmaceutical industry by providing a better understanding of the functioning of enzymes, thereby helping them to develop more specific, targeted drug treatments.
Sectors Chemicals,Education,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology

Description The primary publications from this study have already been cited over 45 times. The citations relate to groups with strong industrial connections in the biotechnological and pharmaceutical sectors. The primary papers include authors from these sectors.
First Year Of Impact 2014
Sector Chemicals,Education,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology
Impact Types Economic

Description BBSRC IAA The University of Manchester
Amount £300,000 (GBP)
Funding ID BB/S506692/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 03/2018 
End 03/2021